Scheckelhoff DJ, Mirtallo JM, Ayers LW, et al. Growth of bacteria and fungi in total nutrient admixtures. Am J Hosp Pharm1986;43:73-7.
2.
Fagerman KE, Paauw JD, McCamish MA, et al. Effects of time, temperature, and preservative on bacterial growth in enteral nutrient solutions. Am J Hosp Pharm1984;41:1122-6.
3.
Kim CK, Lewis DE, Kumar A.Bacterial and fungal growth in intravenous fat emulsions. Am J Hosp Pharm1983;40:2159-61.
4.
Baptista RJ, Palombo JD, Tahan SR, et al. Stability of cimetidine hydrochloride in a total nutrient admixture . Am J Hosp Pharm1985;42:2208-10.
5.
Fink JL III.Legal standard of due care for pharmacists in institutional practice. Am J Hosp Pharm1980;37:1546-9.
6.
Avis KE, moderator. Panel discussion: recent advances in the technology of injectable products. Am J Hosp Pharm1983;40:1940-4.
7.
Avis KE, Akers MJSterile preparation for the hospital pharmacist. Ann Arbor MI: Ann Arbor Science Publishers, 1982.
National Coordinating Committee on Large Volume Parenterals.Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm1975 ;32:261-70.
10.
Jeffrey JP, Mahoney CD, Welch DW, et al. Laminar flow theory and procedures for use of the laminar flow clean bench. Providence RI: Rhode Island Hospital, 1977.
11.
Hale KN, Hale KMAseptic preparation of parenteral products. Bethesda MD : American Society of Hospital Pharmacists, 1985.
12.
Newton DW, Narducci WAExtemporaneous formulations. In King RE , ed. Dispensing of medication. 9th ed. Easton PA: Mack, 1984:258-88.
13.
Bennett WI, ed. AIDS: update (part I). Harv Med Sch Health Lett1985;XI:1-4.
14.
Bryan D., Marback RCLaminar-airflow equipment certification: what the pharmacist needs to know . Am J Hosp Pharm1984;41:1343-9.
15.
Frieben WRControl of the aseptic processing environment. Am J Hosp Pharm1983;40:1928-35.
16.
Arnold TR, Hepler CDBacterial contamination of intravenous fluids opened in unsterile air. Am J Hosp Pharm1971;28:614-9.
17.
Deeb EN, Natsios GAContamination of intravenous fluids by bacteria and fungi during preparation and administration. Am J Hosp Pharm1971;28:764-7.
18.
Morgan E., Fincher JH, Sadik F., et al. Evaluation of laminar flow and nursing station environments for the preparation of intravenous admixtures. Am J Hosp Pharm1972;29:1020-4.
19.
Comroe JH Jr.Physiology of respiration. 2nd ed. Chicago: Year Book Medical Publishers, 1974:230.
20.
Stolar MJAdmixture quality assurance literature check. Parenterals1983;(May/June):2-3.
21.
Brier KLEvaluating aseptic technique of pharmacy personnel. Am J Hosp Pharm1983;40:400-3.
22.
Miller CM, Furtado D., Smith FM, et al. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions. Am J Hosp Pharm1982;39:1302-5.
23.
DeChant RL, Furtado D., Smith FM, et al. Determining a time frame for sterility testing of intravenous admixtures. Am J Hosp Pharm1982;39:1305-8.
24.
Dirks I., Smith FM, Furtado D., et al. Method for testing aseptic technique of intravenous admixture personnel. Am J Hosp Pharm1982;39:457-9.
25.
Gurwich EL, Hanold L., Schaeffer PAA first-phase quality assurance program for intravenous admixture aseptic technique. Hosp Pharm1982;17:119-21.
26.
Posey LM, Nutt RE, Thomson PDComparison of two methods for detecting microbial contamination in intravenous fluids. Am J Hosp Pharm1981;38:659-62.
27.
National Coordinating Committee on Large Volume Parenterals.Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. Am J Hosp Pharm1980;37:645-55.
28.
Morris BG, Avis KE, Bowles GCQuality-control plan for intravenous admixture programs. ii: validation of operator technique. Am J Hosp Pharm1980 ;37:668-72.
29.
Sanders LH, Mabadeje SA, Avis KE, et al. Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures. Am J Hosp Pharm1978 ;35:531-6.
30.
Huey WY, Newton DW, Augustine SC, et al. Microbial contamination potential of sterile disposable plastic syringes. Am J Hosp Pharm1985;42:102-5.
31.
Davis NMQuality i.v. admixture programs. Hosp Pharm1983;18:580.
32.
McGuckin MB , Thorpe RJ, Koch KM, et al. An outbreak of achromobacter xylosoxidans related to diagnostic tracer procedures. Am J Epidemiol1982;11:785-93.
33.
Addi-Chek Quality Control System.Brochure Mello. Bedford MA: Millipore Corp., Medical Products Division, 1978.
34.
Bactec Culture Vials 6, 7, and 8. Brochure PP-014E. Towson MD: Johnston Laboratories, Becton Dickinson and Co, 1983.